Back to search

Article

Subclones of Bone Marrow CD34+ Cells in Acute Myeloid Leukemia at Diagnosis Confer Responses of Patients to Induction Chemotherapy

2021-11-15

Abstract excerpt

<h4>Background: </h4> Acute myeloid leukemia (AML) is a fatal hematopoietic malignancy which has a prognosis that varies with genetic heterogeneity of its hematopoietic stem/progenitor cells(HSCPs). Intensive induction chemotherapy with cytarabine and anthracycline has been the standard of care for newly diagnosed AML, but about 30% of patients have no response to this regimen. The resistance mechanisms require de...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
534eabcc-666d-528c-b753-6d2d6496dbd6
DOI
10.21203/rs.3.rs-1047797/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Subclones of Bone Marrow CD34+ Cells in Acute Myeloid Leukemia at Diagnosis Confer Responses of Patients to Induction ChemotherapyDOI 10.21203/rs.3.rs-1047797/v1
Select a neighboring publication to make it the new centre.